(Q46465304)

22 December 2017

title

The administration of chemotherapy in a patient with Charcot-Marie-Tooth and ovarian cancer (English)

1 reference

22 December 2017

1 reference

Martin A Martino

1

1 reference

22 December 2017

Evan Miller

series ordinal

2

1 reference

22 December 2017

Edward C Grendys

series ordinal

3

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

22 December 2017

published in

Gynecologic Oncology

1 reference

22 December 2017

volume

97

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

page(s)

710-712

1 reference

22 December 2017

Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs. cisplatin and paclitaxel (GOG 158) and an update on GOG0 182-ICON5

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.017

Charcot-Marie-Tooth disease and vincristine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.017

Docetaxel versus paclitaxel for adjuvant treatment of ovarian cancer: case-control analysis of toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.017

Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.017

Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.017

Role of Docetaxel in the Treatment of Newly Diagnosed Advanced Ovarian Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.017

A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.017

Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.017

Toxic neuropathy in patients with pre-existing neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.017

10.1016/J.YGYNO.2005.01.017

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

release_jnqwwmzsg5hbpdnnayhind6d6q

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jnqwwmzsg5hbpdnnayhind6d6q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

22 December 2017